Astellas Pharma Inc. is a global pharmaceutical company with a simple vision – to produce exceptional medicines that change tomorrow for patients in need. Headquartered in Tokyo, Astellas was founded in 2005 through the merger of Yamanouchi and Fujisawa, marrying nearly two centuries of collective experience in producing medicines. We combine the deep expertise brought by this long heritage with the forward-thinking outlook of a young company. At Astellas, a commitment to creating a brighter future is the foundation of everything we do. Our hope is to change tomorrow. To improve the lives of men, women and children by providing innovative medicines in areas of health where there is urgent need for better treatments. Transplant recipients, patients fighting cancer, those with life-threatening infections – these are just some of the patients we are striving to help now and in the future through our single-minded focus on turning innovative science into medical solutions. CHANGING TOMORROW™ is the ethos that guides everything that Astellas does, and is the measure by which we judge our success.